These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15030573)

  • 21. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.
    Waeckerle-Men Y; Starke A; Wahl PR; Wüthrich RP
    Kidney Blood Press Res; 2007; 30(6):421-9. PubMed ID: 17975322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization.
    Ono T; Yanagawa Y; Iwabuchi K; Nonomura K; Onoé K
    Immunology; 2007 Oct; 122(2):189-98. PubMed ID: 17490435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo.
    Levin D; Constant S; Pasqualini T; Flavell R; Bottomly K
    J Immunol; 1993 Dec; 151(12):6742-50. PubMed ID: 7903097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective antigen presenting activity of cortical thymic epithelial cells against CD4+ T cells associated with both lack of costimulatory molecules and inefficient presentation of MHC-peptide ligands.
    Kaneda R; Iwabuchi K; Kasai M; Murakami M; Uede T; Onoé K
    Cell Immunol; 1997 Nov; 181(2):163-71. PubMed ID: 9398403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B7/CD28-dependent and -independent induction of CD40 ligand expression.
    Ding L; Green JM; Thompson CB; Shevach EM
    J Immunol; 1995 Dec; 155(11):5124-32. PubMed ID: 7594521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
    Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA; Bowers WJ; Muller J; Housekneckt V; Giuliano RE; Federoff HJ; Rosenblatt JD
    Cancer Res; 2002 Nov; 62(22):6545-51. PubMed ID: 12438249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion.
    Maxwell JR; Campbell JD; Kim CH; Vella AT
    J Immunol; 1999 Feb; 162(4):2024-34. PubMed ID: 9973474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketamine inhibits maturation of bone marrow-derived dendritic cells and priming of the Th1-type immune response.
    Ohta N; Ohashi Y; Fujino Y
    Anesth Analg; 2009 Sep; 109(3):793-800. PubMed ID: 19690248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Split peripheral tolerance: CD40 ligation blocks tolerance induction for CD8 T cells but not for CD4 T cells in response to intestinal antigens.
    Chung Y; Ko SY; Ko HJ; Kang CY
    Eur J Immunol; 2005 May; 35(5):1381-90. PubMed ID: 15827964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.
    Kaneko K; Wang Z; Kim SH; Morelli AE; Robbins PD; Thomson AW
    Gene Ther; 2003 Jan; 10(2):143-52. PubMed ID: 12571643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.
    Bourgeois C; Rocha B; Tanchot C
    Science; 2002 Sep; 297(5589):2060-3. PubMed ID: 12242444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and duration of contact between dendritic cells and T cells are controlled by T cell activation state.
    Rothoeft T; Balkow S; Krummen M; Beissert S; Varga G; Loser K; Oberbanscheidt P; van den Boom F; Grabbe S
    Eur J Immunol; 2006 Dec; 36(12):3105-17. PubMed ID: 17111349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo.
    Constant S; Schweitzer N; West J; Ranney P; Bottomly K
    J Immunol; 1995 Oct; 155(8):3734-41. PubMed ID: 7561077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo.
    Constant SL
    J Immunol; 1999 May; 162(10):5695-703. PubMed ID: 10229801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
    Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
    Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.